Narrative review of opsoclonus myoclonus ataxia syndrome following COVID-19
5 June 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
COVID-19, SARS-CoV-2, complications, myoclonus, neuro-COVID, opsoclonus
Opsoclonus myoclonus syndrome (OMS) / opsoclonus myoclonus ataxia syndrome (OMAS) is a rare central nervous system manifestation of COVID-19, but an increasing number of articles have reported patients in whom COVID-19 was complicated by OMS / OMAS. This narrative review...
Risk stratification to reduce intraoperative cataract surgical complications
3 June 2021
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Phacoemulsification, complications, posterior capsule rupture, risk stratification
The authors prospectively collected data on 1135 consecutive patients undergoing cataract surgery. They were risk stratified according to categories – A (no additional risk factors, 0 points), B (vitrectomy, corneal scarring, small pupil less than 3mm, shallow anterior chamber less...
Practical application of cataract risk stratification
5 August 2020
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
cataract surgery, surgical complication, vocational training
This study assessed the practicability of a risk stratification system, the New Zealand Cataract Risk Stratification (NZCRS) in a major teaching hospital. The scoring system was as follows: three points for Dense cataract, pseudoexfoliation (PXF), phacodonesis, previous vitrectomy and only...
Outcomes of cataract surgery in eyes with weak zonules
1 April 2017
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
capsular tension ring, cataract, phacoemulsification, postoperative complications, pseudoexfoliation, weak zonules
Pseudoexfoliation (PEX) and zonular weakness have long been known to increase the risk of complication of cataract surgery. This retrospective study looks at the results of phacoemulsion and intraocular implantation in 295 eyes with pseudoexfoliation and zonular weakness, with a...
Bisphosphonates can cause orbital inflammation
1 April 2016
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Bisphosphonate, complication, orbital inflammation, orbital inflammatory syndrome, side effect, zolendronate
The authors describe four patients with bisphosphonate induced orbital inflammation and review a further 25 cases in the literature. Intravenous zoledronate was the most common precipitant (76% of cases) with the mean time until onset of inflammation being three days...
